Clinical Trials
3 trialsNCT04905407 2025-02-24
Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Syros Pharmaceuticals
Phase 2 Terminated
NCT00985530 2013-10-30
Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia
Northwestern University
Phase 1 Terminated
NCT01337154 2013-06-28
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
CytRx
Phase 2 Terminated